Research
Oct 2025 Research Roundup
A look at our recent visit to Belfast for the BASL conference and Information Day
Read MoreGlobal PSC Awareness Day 2025
The 29th of October 2025, marks Global PSC Awareness Day, a day that unites patients, families, clinicians, and researchers around the world to shine a light on PSC.
This year’s theme, “Turning Hope into Action,” is about more than optimism, it’s about progress. Every day, people affected by PSC, along with the medical and research community, are taking steps toward finding effective treatments and, ultimately, a cure.
Read MoreSep 2025 Research Roundup
Read about our latest research activities.
Read MoreAssessing Quality of Life in PSC
We’re working with researchers to develop tools to measure symptoms and quality of life in PSC.
Read MoreJuly 2025 Research Roundup
Read the latest updates on the SPRING trial, the NHS 10 Year Health Plan, how we are funding research this year and how PSC Support is influencing real change in research and policy.
Read MoreVolunteer Research Admin Support Role
Help Drive PSC Research Forward!
There’s never been a more exciting time to get involved in PSC research. We’ve got more clinical trials and research projects happening than ever before – and it’s making a real difference. On top of academic and commercial studies, PSC Support has directly funded over £750,000 of cutting-edge research in just the last two years.
June 2025 Research Roundup
Read a research update from Martine Walmsley for June 2025.
Read MoreMay 2025 Research Roundup
Research Roundup May 2025 Links Learning from PBC Bile Duct Cancer Conference Research YOU’VE funded International Liver Research Conference (with major PSC announcements) Watch Ask the Expert with Dr Trivedi Learning from PBC This month, I attended a meeting of PBC experts in Amsterdam who want to understand what evidence is required to show that…
Read MoreClinical Trial for Elafibranor
Encouraging results from the ELMWOOD clinical trial.
Read MoreClinical Trial for Norucholic Acid – Latest Results
Positive results from the Phase 3 NUC-5 clinical trial.
Read More